Uipath [PATH] vs Nutanix [NTNX] Detailed Stock Comparison

Uipath Inc.

NYSE
Loading...

Nutanix, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Uipath Inc. wins in 11 metrics, Nutanix, Inc. wins in 9 metrics, with 0 ties. Uipath Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Uipath Inc. Nutanix, Inc. Better
P/E Ratio (TTM) 19.40 37.40 Uipath Inc.
Price-to-Book Ratio 2.60 -11.11 Uipath Inc.
Debt-to-Equity Ratio 3.90 -1.86 Uipath Inc.
PEG Ratio 0.17 0.46 Uipath Inc.
EV/EBITDA 51.57 29.87 Nutanix, Inc.
Profit Margin (TTM) 17.53% 9.95% Uipath Inc.
Operating Margin (TTM) 16.69% 11.64% Uipath Inc.
EBITDA Margin (TTM) 16.69% 11.64% Uipath Inc.
Return on Equity 14.37% -27.12% Uipath Inc.
Return on Assets (TTM) 1.27% 4.44% Nutanix, Inc.
Free Cash Flow (TTM) $352.16M $750.17M Nutanix, Inc.
1-Year Return -13.81% -31.64% Uipath Inc.
Price-to-Sales Ratio (TTM) 3.28 3.46 Uipath Inc.
Enterprise Value $3.90B $8.80B Nutanix, Inc.
EV/Revenue Ratio 2.42 3.28 Uipath Inc.
Gross Profit Margin (TTM) 84.63% 87.37% Nutanix, Inc.
Revenue per Share (TTM) $3 $10 Nutanix, Inc.
Earnings per Share (Diluted) $0.52 $0.92 Nutanix, Inc.
Beta (Stock Volatility) 1.03 0.52 Nutanix, Inc.
Short % of Float 25.55% 6.25% Nutanix, Inc.

Uipath Inc. vs Nutanix, Inc. Stock Performance Analysis

Loading Price Chart...

PATH
NTNX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Uipath Inc.2.27%-3.40%5.06%-6.74%-33.23%-32.05%
Nutanix, Inc.-1.13%-8.07%11.06%26.02%3.64%-2.55%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Uipath Inc.-13.81%-41.71%-84.87%-85.90%-85.90%-85.90%
Nutanix, Inc.-31.64%68.93%33.63%33.27%33.27%33.27%

Performance & Financial Health Analysis: Uipath Inc. vs Nutanix, Inc.

MetricPATHNTNX
Market Information
Market Cap i$5.29B$9.30B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i24,831,7193,690,740
90 Day Avg. Volume i26,861,6234,718,617
Last Close$10.79$72.76
52 Week Range$9.20 - $19.84$43.35 - $83.36
% from 52W High-45.61%-12.72%
All-Time High$90.00 (May 24, 2021)$83.36 (May 19, 2025)
% from All-Time High-88.01%-12.72%
Growth Metrics
Quarterly Revenue Growth0.14%0.10%
Quarterly Earnings Growth1.02%0.83%
Financial Health
Profit Margin (TTM) i0.18%0.10%
Operating Margin (TTM) i0.17%0.12%
Return on Equity (TTM) i0.14%-0.27%
Debt to Equity (MRQ) i3.90-1.86
Cash & Liquidity
Book Value per Share (MRQ)$3.88$-3.13
Cash per Share (MRQ)$2.81$7.07
Operating Cash Flow (TTM) i$371.21M$832.21M
Levered Free Cash Flow (TTM) i$473.55M$664.85M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Uipath Inc. vs Nutanix, Inc.

MetricPATH (Apr 24, 2026)NTNX (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i19.4037.40
Forward P/E i11.2615.95
PEG Ratio i0.170.46
Price to Sales (TTM) i3.283.46
Price to Book (MRQ) i2.60-11.11
Market Capitalization
Market Capitalization i$5.29B$9.30B
Enterprise Value i$3.90B$8.80B
Enterprise Value Metrics
Enterprise to Revenue i2.423.28
Enterprise to EBITDA i51.5729.87
Risk & Other Metrics
Beta i1.030.52
Book Value per Share (MRQ) i$3.88$-3.13

Financial Statements Comparison: Uipath Inc. vs Nutanix, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPATH (2026)NTNX (2025)
Revenue/Sales i1.61B2.54B
Cost of Goods Sold i270.98M334.78M
COGS % of Revenue i16.8%13.2%
Gross Profit i1.34B2.20B
Gross Margin i83.2%86.8%
Research & Development i385.21M736.82M
Operating Income (EBIT) i56.76M172.54M
Operating Margin i3.5%6.8%
EBITDA i73.73M292.73M
EBITDA Margin i4.6%11.5%
Pre-Tax Income i100.63M211.65M
Pre-Tax Income % of Revenue i6.2%8.3%
Income Tax i-181.70M23.28M
Income Tax % of Revenue i-11.3%0.9%
Net Income (Profit) i282.33M188.37M
Profit Margin i17.5%7.4%

Balance Sheet & Liquidity Metrics

MetricPATH (2026)NTNX (2025)
Cash & Equivalents i871.16M769.50M
Total Current Assets i2.24B2.59B
Total Current Assets % of Revenue i139.3%102.0%
Total Current Liabilities i905.42M1.41B
Total Current Liabilities % of Revenue i56.2%55.7%
Long-Term Debt i70.94M1.46B
Long-Term Debt % of Revenue i4.4%57.5%
Total Shareholders Equity i2.08B-694.52M
Retained Earnings i-1.71B-4.90B
Retained Earnings % of Revenue i-105.9%-192.9%
Property, Plant & Equipment i65.30M276.54M

Cash Flow Statement Comparison

MetricPATH (2026)NTNX (2025)
Operating Cash Flow i330.36M800.54M
Operating Cash Flow % of Revenue i20.5%31.5%
Capital Expenditures i-19.05M-71.28M
Free Cash Flow i352.16M750.17M
FCF Margin i21.9%29.6%
Debt Repayment iN/A-102.88M
Common Stock Repurchase i-329.10M-307.90M

Short Interest & Institutional Ownership Analysis

MetricPATHNTNX
Shares Short i93.39M12.17M
Short Ratio i2.482.01
Short % of Float i25.55%6.25%
Shares Outstanding i537.04M265.63M
Float Shares i416.15M263.51M
% Held by Insiders i9.44%0.44%
% Held by Institutions i80.61%93.66%
% Held by Public i9.95%5.90%

Dividend Analysis & Yield Comparison: Uipath Inc. vs Nutanix, Inc.

MetricPATHNTNX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A